United States · FDA National Drug Code directory
Cyclobenzaprine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69097-845_e41dbd69-00e7-40f4-a9e7-626965badd27
- Product NDC
- 69097-845
- Form
- TABLET, FILM COATED
- Composition / generic term
- Cyclobenzaprine
- Labeler
- Cipla USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160722
- Source listing expiry
- 20271231
Source-listed ingredients
- CYCLOBENZAPRINE HYDROCHLORIDE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED in 1 BOTTLE (69097-845-07) · 69097-845-07
- 1000 TABLET, FILM COATED in 1 BOTTLE (69097-845-15) · 69097-845-15
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →